Loading ...Coronavirus treatment using existing drug update
Northstar your good question answered:
Forbes and todays Whitehouse briefing.
FDA Approved Anti-Malaria Drug Chloroquine To Test As Coronavirus Treatment
From Indian treatment:
“Their symptoms were flu-like so they were initially given anti-malaria and anti-swine flu drugs,” he said.
“All this while, our doctors were in touch with the Indian Council of Medical Research and the Drug Controller General of India. Since the structure of coronavirus is similar to that of HIV to some extent, so they tried a combination of the two anti-HIV drugs,” he added.
Hydroxychloroquine has already been in clinical trials in France and has proven its efficacy, and even more so when paired with Azithromycin.
It is a no-brainer to use already available and inexpensive drugs. As usual the US is behind the curve, and is just starting to investigate this.
https://drive.google.com/file/d/186Bel9RqfsmEx55FDum4xY_IlWSHnGbj/view
You may have already seen this paper, as I posted this it last night on the Enough Virus thread.
Here are the protocols and results of this clinical trial
Background
Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2, and
reported to be efficient in Chinese COV-19 patients. We evaluate the role of
hydroxychloroquine on respiratory viral loads.
Patients and methods
French Confirmed COVID-19 patients were included in a single arm protocol from early
March to March 16th, to receive 600mg of hydroxychloroquine daily and their viral load in
nasopharyngeal swabs was tested daily in a hospital setting. Depending on their clinical
presentation, azithromycin was added to the treatment. Untreated patients from another center
and cases refusing the protocol were included as negative controls. Presence and absence of
virus at Day6-post inclusion was considered the end point.
Results
Six patients were asymptomatic, 22 had upper respiratory tract infection symptoms and eight
had lower respiratory tract infection symptoms.
Twenty cases were treated in this study and showed a significant reduction of the viral
carriage at D6-post inclusion compared to controls, and much lower average carrying duration
than reported of untreated patients in the literature. Azithromycin added to
hydroxychloroquine was significantly more efficient for virus elimination.
Conclusion
4
Despite its small sample size our survey shows that hydroxychloroquine treatment is
significantly associated with viral load reduction/disappearance in COVID-19 patients and its
effect is reinforced by azithromycin.
These drugs are available in abundance everywhere.
Chloroquine is an anti viral ( anti malarial)
Zithromax is an antibiotic ( antibacterial)
And these drugs are extremely cheap. We’re in an Rx Savings Club & can get HCQ for $6.00 and a Z-pack for $3.88
I’ve already messaged my Doc to ask if they are considering prescribing these off-label until FDA approval. What a victory that would be!
Instead of sending helicopter money, they should mail everybody these drugs. Some docs think they work well prophylactically too for CoV.
… Seek the positive, and ye shall find!! 🙂
Well, this is what I got back from my Doc:
‘Hydroxychloroquine is still considered investigational and only being used in critically ill covid infected patients. It has a lot of side effects and requires an eye exam before prescribing and it causes severe low white blood cell count.’
https://www.healthwarehouse.com/hydroxychloroquine-200mg-tablets-generic-plaquenil.html
https://www.blinkhealth.com/hydroxychloroquine